drugset / Trial / NCT00391027

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

NCT00391027

Phase 4 Completed 261 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare efficacy and safety of Exubera® vs Lantus® in patients with type 2 diabetes mellitus.

Timeline

Start
2006-12
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Inhaled
Comparator insulin glargine Protein / enzyme biologic